chemic
synthes
short
interf
rna
sirna
usher
new
era
applic
rna
interfer
rnai
viral
gene
paid
particular
attent
respiratori
virus
wreak
heavi
morbid
mortal
worldwid
clinic
signifi
cant
one
includ
respiratori
syncyti
viru
rsv
parainfl
uenza
viru
piv
two
paramyxovirus
infl
uenza
viru
orthomyxoviru
infect
virus
clinic
restrict
respiratori
tissu
mainli
lung
logic
rout
applic
sirna
also
ie
via
nasal
rout
follow
initi
success
singl
intranas
sirna
rsv
offer
two
new
strategi
secondgener
sirna
use
paramyxovir
rna
polymeras
larg
subunit
l
sirna
cocktail
novel
transfect
reagent
use
infl
uenza
viru
base
result
propos
follow
consensu
design
intranas
antivir
sirna
modifi
ed
ntlong
doublestrand
sirna
function
lung
b
excess
modifi
cation
either
strand
sirna
reduc
effi
caci
c
limit
modifi
cation
sens
strand
benefi
cial
although
precis
effi
caci
may
positiondepend
cocktail
multipl
sirna
highli
effect
multipl
viral
strain
subtyp
short
interf
rna
sirna
trigger
posttranscript
gene
silenc
varieti
metazoan
cell
tissu
success
use
synthet
doublestrand
sirna
target
cellular
viral
gene
cell
cultur
open
door
sirna
prospect
antivir
drug
gene
therapi
fi
rstgener
sirna
design
mimic
product
dicer
endonucleas
cleavag
ntlong
duplex
nt
overhang
contain
natur
unmodifi
ed
ribos
base
report
us
sever
laboratori
sirna
prove
effect
cell
cultur
anim
effect
treat
infect
rel
nonspecifi
c
toxic
regard
molecular
featur
rsv
piv
nonseg
negativestrand
rna
virus
belong
differ
genera
paramyxovirida
famili
contrast
fl
u
orthomyxoviru
contain
segment
negativestrand
rna
genom
coronovirus
sarscov
contain
positivestrand
rna
genom
common
among
rna
virus
encod
gene
rnadepend
rna
polymeras
rdrp
transcrib
replic
genom
host
anim
cell
devoid
activ
mani
potent
antivir
sirna
therefor
target
viral
gene
code
rdrp
subunit
protein
relat
rdrp
function
earli
studi
target
p
phosphoprotein
l
larg
see
tabl
n
nucleocapsid
gene
rsv
p
l
gene
piv
pa
np
gene
flu
replicas
gene
sarscov
case
sirna
design
essenti
viral
gene
optim
cell
cultur
use
intranas
appropri
anim
model
antivir
activ
shown
rsv
parainfl
uenza
viru
piv
use
balbc
mous
model
well
studi
optim
result
obtain
sirna
deliv
complex
either
subhead
although
uncomplex
intranas
sirna
also
show
effi
caci
intranas
sirna
complex
oligofectamin
polyethyleneimin
pei
also
protect
highli
pathogen
infl
uenza
virus
subtyp
mice
notwithstand
success
activ
sirna
transient
last
day
therefor
enhanc
intracellular
extracellular
stabil
synthet
sirna
increas
without
compromis
rnai
activ
continu
goal
therapeut
translat
rnai
varieti
chemic
modifi
cation
includ
termin
intern
one
ad
fi
rstgener
sirna
sequenc
improv
stabil
deliveri
lead
call
secondgener
sirna
advantag
taken
free
group
ribos
moieti
rna
contrast
dna
lack
oh
group
variou
substitu
ad
pursu
two
promis
one
name
uorid
latter
modif
place
pyrimidin
nucleosid
c
u
lead
residu
number
previou
studi
substitut
introduc
variou
extent
antisens
strand
guid
strand
strand
sirna
shown
enhanc
stabil
potenc
although
intranas
applic
test
addit
tend
reduc
sirnadriven
innat
immun
respons
systemat
studi
cell
cultur
biochem
function
activ
sirna
vindic
found
affect
posit
modifi
cation
sequenc
gener
speak
modifi
ed
ribonucleotid
antisens
strand
less
activ
rel
ed
one
intern
gener
welltoler
antisens
strand
show
signifi
cant
shift
activ
depend
posit
contrast
incorpor
sens
strand
sirna
show
strong
posit
prefer
comprehens
studi
howev
intern
modifi
cation
either
strand
actual
made
sirna
less
activ
anim
experi
residu
sirna
hepat
b
viru
substitut
administ
intraven
iv
lipid
complex
sirna
show
improv
effi
caci
longer
halflif
plasma
liver
sirna
addit
reveal
accumul
liver
spleen
lung
explain
success
iv
administr
hepat
suggest
ineffect
rout
lung
infect
base
absenc
uniform
pattern
studi
reason
sirna
respiratori
virus
individu
optim
follow
step
design
fi
rstgener
sirna
follow
gener
accept
sequenc
rule
algorithm
choic
select
one
lowest
ic
prefer
nm
cell
cultur
assay
viru
growth
desir
rsv
tabl
add
ome
f
substitut
variou
format
ie
number
placement
gener
modifi
ed
secondgener
sirna
ensur
substitut
either
improv
reduc
knockdown
effi
cienci
screen
cell
cultur
confi
rm
effi
caci
lack
toxic
anim
model
test
improv
stabil
serum
blood
vitro
final
deem
necessari
resourc
permit
lowor
highthroughput
assay
offtarget
effect
perform
ensur
target
specifi
citi
togeth
small
repres
dataset
cover
multipl
virus
modifi
ed
unmodifi
ed
sirna
present
consensu
procedur
test
laboratori
essenti
protocol
use
test
modifi
cation
deliveri
reagent
becom
avail
fl
u
exampl
found
hk
polym
fact
better
number
reagent
test
fig
reagent
describ
use
success
us
variou
equival
avail
commerci
optim
assum
reader
access
appropri
cell
cultur
facil
consist
incub
cultur
hood
avail
expertis
viru
growth
assay
chapter
cover
specifi
c
issu
relat
test
antivir
sirna
rsv
rnasefre
gelload
microcapillari
tip
vwr
rnasefre
microfug
tube
ambion
use
free
onlin
sirna
design
program
target
mrna
sequenc
see
note
gener
use
one
avail
whitehead
institut
mit
server
follow
url
http
sirnawimitedu
registr
requir
free
copi
past
target
sequenc
box
initi
choos
aan
tt
recommend
pattern
usual
need
chang
filter
criteria
ie
leav
default
click
search
button
rsv
l
gene
found
mani
prospect
one
tabl
sirna
obtain
gene
sequenc
repeat
procedur
time
choos
nan
fl
u
proprietari
algorithm
use
thu
sirna
sequenc
fig
also
intellectu
properti
gener
wider
coverag
multipl
viru
strain
minim
resist
choos
viral
sequenc
conserv
lead
tabl
prospect
sirna
sequenc
order
accord
thermodynam
valu
default
set
goal
select
sequenc
high
neg
valu
ie
sequenc
closer
top
tabl
addit
visual
examin
central
n
part
ie
ignor
fi
rst
two
last
two
nucleotid
pick
one
atrich
right
hand
side
gcrich
high
effi
cienci
hk
polym
sirna
transfect
propreitari
sirna
human
cyclophilin
b
mrna
test
deliveri
cell
use
follow
reagent
hisli
polym
hkp
select
branch
cation
lipid
dotap
glucos
dextros
water
common
physiolog
solut
use
clinic
blank
sirna
administ
transfect
reagent
note
strong
perform
hkp
especi
discern
sirna
left
hand
side
number
sequenc
one
test
realli
depend
avail
resourc
order
least
given
target
order
sens
strand
n
dtdt
antisens
strand
dtdt
part
complementari
n
sequenc
provid
exampl
test
function
sirna
sequenc
base
l
polymeras
gene
rsv
tabl
assum
receiv
sirna
roughli
week
order
purchas
smallest
amount
initi
save
money
gener
nmol
aliquot
sirna
small
volum
store
best
result
freezethaw
four
time
trypsin
cell
seed
cell
complet
growth
medium
per
well
plate
incub
h
achiev
confl
uenci
immedi
transfect
add
optimem
steril
eppendorf
tube
add
transittko
reagent
mix
thoroughli
vortex
incub
room
temperatur
min
add
volum
dilut
transfect
reagent
made
step
mix
gentl
pipet
incub
room
temperatur
min
adjust
medium
volum
well
cell
monolay
step
remov
half
origin
volum
tabl
order
modifi
ed
sirna
commerci
sourc
eg
dharmacon
process
step
subhead
prior
intranas
administr
sirna
mous
see
note
must
anesthet
use
standard
procedur
avail
laboratori
eg
administ
nembut
via
recent
rel
larg
nt
long
doublestrand
rna
act
dicer
substrat
dsirna
shown
potent
regular
nt
sirna
use
also
found
least
potent
fi
rst
second
gener
sirna
term
intranas
antirsv
activ
without
increas
immun
reaction
preliminari
experi
also
lent
well
modifi
cation
intranas
antivir
activ
data
shown
recommend
exact
format
optim
sequenc
follow
publish
dsirna
design
guidelin
although
describ
laboratori
mous
model
intranas
dosag
deliveri
easili
scale
laboratori
anim
sirna
concentr
pharmaceut
industri
prefer
express
drug
concentr
wtvol
wtbodi
weight
eg
mgkg
research
howev
easier
use
express
sirna
concentr
molar
unit
eg
nm
sinc
allow
direct
comparison
potenc
differ
sirna
even
differ
base
composit
modifi
cation
henc
formula
weight
transfect
reagent
sirna
may
respond
differ
differ
reagent
experi
deliveri
reagent
choic
fig
avoid
use
excess
liquid
may
suffoc
anim
caus
death
rule
keep
total
instil
volum
balbc
mice
higher
volum
may
toler
larger
speci
protocol
describ
may
modifi
ed
aerosol
sirna
use
enclosur
hous
anesthet
anim
handheld
nebul
common
type
use
inhal
asthmat
larger
amount
sirna
need
fraction
aerosol
actual
inhal
anim
use
routin
consid
optim
commerci
motor
nebul
check
local
pediatrician
exact
model
vendor
usag
modifi
system
remov
facial
mask
deliveri
end
insert
tube
directli
enclosur
snug
fi
mask
reduc
sirna
wast
